Frontiers | Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis
Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer | Modern Pathology
PSMA in Advanced Prostate Cancer
Frontiers | New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
Cancers | Free Full-Text | PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
PET-CT in prostate cancer (PSMA-PET/CT) - Praxis für Nuklearmedizin PET-CT Zentrum
SciELO - Brasil - Clinical perspectives of PSMA PET/MRI for prostate cancer Clinical perspectives of PSMA PET/MRI for prostate cancer
SciELO - Brasil - Clinical perspectives of PSMA PET/MRI for prostate cancer Clinical perspectives of PSMA PET/MRI for prostate cancer
Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings | Cancer Imaging | Full Text
PSMA PET Scan for Prostate Cancer | UCSF Radiology
Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies | Nature Reviews Urology
PSMA-Targeted Radiotracer Pinpoints Metastatic Prostate Cancer Across Anatomic Regions | Imaging Technology News
Prostate Cancer Antibodies used in Immunohistochemistry | LSBio
IJMS | Free Full-Text | A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges | HTML
A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile | Scientific Reports
Prostate-specific Membrane Antigen PET: Therapy Response Assessment in Metastatic Prostate Cancer | RadioGraphics
Frontiers | New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
Cancers | Free Full-Text | PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
Cancers | Free Full-Text | PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer | NEJM
68 Ga-PSMA PET/CT for primary staging of Gleason score 5 + 4, PSA 12.9... | Download Scientific Diagram
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer | Nature Reviews Urology
Example of PSMA-PET-targeted therapy of the oligoprogressive primary... | Download Scientific Diagram
FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News
